Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Andrew M. Goldfine, MD
Sr. Clinical Development Director
GlaxoSmithKline plc
Poster(s):
148: PK/PD Modeling of Progranulin Elevation in Blood & CSF to Support AL101 Dose Selection & Phase 2 Study Design
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT